Dec 17
Current report
8-K
Events of Dec 15
Entered into a material agreement, New debt or off-balance-sheet obligation
ICCC · Immucell Corp · Documents
$9.80
-0.15 (-1.51%)
At close · Nov 6
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Market Cap
$90.37M
Shares
9.08M
Volume · Nov 6
8244
Avg daily vol (3M)
16.72K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
2020
Nov 12
Earnings call
Q3 2020 earnings call
Nov 12
Current report
8-K
Financial results
Nov 12
Quarterly report
10-Q
FY2020 Q3, ended Sep 30
Quarterly report for FY2020 Q3
Revenue $3.72M
▲ 25.3%
Net loss $322.89K
Diluted EPS -$0.04
Oct 6
Current report
8-K
Financial results
Aug 12
Current report
8-K
Financial results
Aug 12
Quarterly report
10-Q
FY2020 Q2, ended Jun 30
Quarterly report for FY2020 Q2
Revenue $2.97M
▲ 9.4%
Net loss $765.79K
Diluted EPS -$0.11
Jul 7
Earnings call
Q2 2020 earnings call
Jul 7
Current report
8-K
Financial results
Jun 16
Current report
8-K
Events of Jun 12
Entered into a material agreement, New debt or off-balance-sheet obligation
Jun 11
Current report
8-K
Events of Jun 10
Charter or bylaw amendment, or fiscal year change, Shareholder vote results
May 15
Current report
8-K
Events of May 14
Regulation FD disclosure, Other events
May 14
Current report
8-K
Other events
May 13
Earnings call
Q1 2020 earnings call
May 13
Current report
8-K
Financial results
May 13
Quarterly report
10-Q
FY2020 Q1, ended Mar 31
Quarterly report for FY2020 Q1
Revenue $4.91M
▲ 11.3%
Net loss $122.27K
Diluted EPS -$0.02
Apr 28
Proxy statement
DEF 14A
Meeting Jun 10, 2020
Proxy statement
Apr 14
Current report
8-K
Events of Apr 13
Entered into a material agreement, New debt or off-balance-sheet obligation
Apr 14
Proxy statement
PRE 14A
Proxy statement
Apr 2
Current report
8-K
Financial results
Mar 27
Annual report
10-K
FY2019, ended Dec 31
Annual report for FY2019
Revenue $13.72M
▲ 24.9%
Net loss $1.3M
Diluted EPS -$0.19
Mar 12
Current report
8-K
Events of Mar 11
Entered into a material agreement, New debt or off-balance-sheet obligation
Feb 19
Current report
8-K/A
Events of Feb 18
Financial results
Feb 18
Current report
8-K
Financial results
Jan 22
Current report
8-K
Events of Jan 21
Financial results
Showing 151–175 of 175 documents